Skip to main content
Retour
Watch Compare

NIKA PHARMACEUTICALS, INC

Qualité des données : 83%
NIKA
OTC Manufacturing Chemicals
0,75 €
0,00 € (0,00%)
Cap. Boursière: 785,03 M
Prix
0,75 €
Cap. Boursière
785,03 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -79 654,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-218,55%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,08
Interest CoverageN/A

Valorisation

PE (TTM)
-10275,58
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -10275,6 -1,5
P/B — 1,6
ROE % — -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -76 398,0
ROE N/A ROA -276,64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -79 654,0
ROIC -218,55% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,08
Interest Coverage N/A Asset Turnover N/A
Working Capital -260 539 Tangible Book Value -260 539
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10275,58 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,01%
Market Cap 785,03 M Enterprise Value 785,31 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 104,26%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — 0,0 0,0 0,0 —
Net Income -76 398,0 -95 792,0 -64 833,0 -3,18 M -8 907,0
EPS (Diluted) 0,00 0,00 — 0,00 —
Gross Profit — — — — —
Operating Income -76 398,0 -95 792,0 -64 833,0 -3,18 M -8 907,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 20 996,0 17 934,0 19 596,0 864,0 1 611,0
Total Liabilities 318 624,0 239 164,0 101 745,0 18 180,0 10 518,0
Shareholders' Equity -297 628,0 -221 230,0 -82 149,0 -17 316,0 -8 907,0
Total Debt 318 624,0 239 164,0 — — —
Cash & Equivalents 1 889,0 2 083,0 19 596,0 864,0 —
Current Assets 20 996,0 17 934,0 19 596,0 864,0 1 611,0
Current Liabilities 318 624,0 239 164,0 101 745,0 18 180,0 —